Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
3,997,925
Value
$361.7M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of EW by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,997,925$361.7M0.2%+3,478,894+670.3%AddedHolders
Q1 2026519,031$41.6M<0.1%−1,684,896−76.4%ReducedHolders
Q4 20252,203,927$187.9M0.1%−2,030,643−48.0%ReducedHolders
Q3 20254,234,570$329.3M0.3%−8,496,721−66.7%ReducedHolders
Q2 202512,731,291$995.7M0.9%−650,392−4.9%ReducedHolders
Q1 202513,381,683$969.9M0.9%+3,963,609+42.1%AddedHolders
Q4 20249,418,074$697.2M0.6%+7,426,571+372.9%AddedHolders
Q3 20241,991,503$131.4M0.1%+1,367,102+218.9%AddedHolders
Q2 2024624,401$57.7M0.1%−2,020,994−76.4%ReducedHolders
Q1 20242,645,395$252.8M0.2%+2,339,486+764.8%AddedHolders
Q4 2023305,909$23.3M<0.1%−284,211−48.2%ReducedHolders
Q3 2023590,120$40.9M<0.1%+584,521+10,439.7%AddedHolders
Q2 20235,599$528.2K<0.1%−986,634−99.4%ReducedHolders
Q1 2023992,233$82.1M0.1%+515,843+108.3%AddedHolders
Q4 2022476,390$35.5M<0.1%+114,083+31.5%AddedHolders
Q3 2022362,307$29.9M<0.1%+353,476+4,002.7%AddedHolders
Q2 20228,831$840.0K<0.1%−9,460−51.7%ReducedHolders
Q1 202218,291$2.15M<0.1%−13,713−42.8%ReducedHolders
Q4 202132,004$4.15M<0.1%−147,901−82.2%ReducedHolders
Q3 2021179,905$20.4M<0.1%+109,725+156.3%AddedHolders
Q2 202170,180$7.27M<0.1%−671,205−90.5%ReducedHolders
Q1 2021741,385$62.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.